Skin Cancer

Skin Cancer

Metastatic Uveal Melanoma: Darovasertib/Crizotinib Evaluated as First-Line Targeted Therapy

November 12 2 min read
In the phase I/II OptimUM-01 trial, the doublet demonstrated antitumor activity and a manageable safety profile in patients with previously untreated metastatic uveal melanoma.

Latest in Skin Cancer